Novel bradykinin-1 antagonists containing a (1,2,3,4-tetrahydro-isoquinolin-1-yl)acetic acid scaffold

Novel B1 antagonist core 1,2,3,4-tetrahydroisoquinolin-1-ylacetic acid was utilized and the effect of modification of its amide side chain on the biological activity was tested.